Click here for updates and notices regarding Nova Scotia Health and COVID-19
Dr. Amanda Caissie is focused on digital oncology, patient engagement and artificial intelligence. Through her roles at Nova Scotia Health as an innovator in residence and Medical Director of the Cancer Care Program’s Oncology Transformation Project, she aims to align clinical and research priorities for digital health solutions, advancing research and innovation across the continuum of cancer care and beyond.
Dr. Caissie, MD, Ph.D., FRCPC, is an Associate Professor and Department Head (interim) at Dalhousie University’s Department of Radiation Oncology (DRO). A native Maritimer, she returned to work at Dalhousie after completing medical school at Queen’s University in 2007 and a radiation oncology residency at the University of Toronto in 2012. A McGill alumna who completed her Ph.D. in 2005, Dr. Caissie’s current research interests focus on Patient Reported Outcomes and Big Data as radiotherapy quality improvement (QI) initiatives fostered through inter-disciplinary collaborations such as the Learning from Analysis of Multicentre Big Data Aggregation (LAMBDA) consortium. She is co-founder/co-lead of the recently formed Canadian Artificial intelligence and big Data in Radiotherapy Alliance (CADRA). Other contributions to national and international radiotherapy QI initiatives include being Chair of the Canadian Association of Radiation Oncology (CARO) Quality and Standards Committee, committee member of the American Association of Physicists in Medicine (AAPM)’s Big Data Subcommittee and Canadian Partnership for Quality Radiotherapy (CPQR), as well as international liaison in the European Association of Radiation Oncology (ESTRO)’s Radiation Oncology Safety and Quality Committee (ROSQ).